aMRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, United Kingdom;
bDepartment of Respiratory Sciences, University of Leicester, Leicester, United Kingdom;
cLondon School of Hygiene and Tropical Medicine, London, United Kingdom;
dDepartment of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland;
eDepartment of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montréal, QC, Canada;
fBristol Veterinary School, University of Bristol, Bristol, United Kingdom; and
gPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
Correspondence to: Romain Silhol, PhD, Department of Infectious Disease Epidemiology, MRC Centre for Global Infectious Disease, Analysis, Imperial College London, St Mary's Hospital, 2 Norfolk Place, W2 1PG London, United Kingdom (e-mail: [email protected]).
K.J.L. and K.M.E.T. report a grant from GSK outside the submitted work. This work was funded by the World Health Organization, through the UNDP-UNFPAUNICEF-WHO-World Bank Special Program of Research, Development, and Research Training in Human Reproduction, a cosponsored program executed by the WHO, and through support from the US National Institute of Allergy and Infectious Diseases, part of the US National Institutes of Health (NIH) (NIH U01 AI108543). This work was partly supported by the HPTN Modelling Centre, which is funded by the NIH (NIH UM1 AI068617) through the HPTN Statistical and Data Management Center. R.S., H.L.C., R.F.B., J.S., L.S., and M.C.B. acknowledged funding from the MRC Centre for Global Infectious Disease Analysis (reference MR/R015600/1), jointly funded by the UK Medical Research Council (MRC) and the UK Foreign, Commonwealth, and Development Office (FCDO), under the MRC/FCDO Concordat agreement and are also part of the EDCTP2 program supported by the European Union. S.G. acknowledged additional funding support from NIH (U01AI139547). K.J.L. and K.M.E.T. thank the National Institute for Health Research (NIHR) Health Protection Research Unit (HPRU) in Evaluation of Interventions at the University of Bristol, in partnership with Public Health England (PHE), for research support. RH received funding from the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement, which is also part of the EDCTP2 program supported by the European Union. Grant Ref: MR/R010161/1. R.F.B. is supported by a Wellcome Trust Institutional Strategic Support Fund Fellowship (204801/Z/16/Z). P.V. also acknowledged support from the NIHR Health Protection Research Unit in Behavioural Science and Evaluation at University of Bristol. The authors alone are responsible for the views expressed in this article, and they do not necessarily represent the views, decisions, or policies of the institutions with which they are affiliated, the WHO, the NHS, the NIHR the Department of Health and Social Care, or Public Health England. The remaining authors have no conflicts of interest to disclose.
K.J.L and M-C.B. have contributed equally to the work.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.jaids.com).
